FYI - https://clinicaltrials.gov/ct2/show/NCT04341012

Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
ClinicalTrials.gov Identifier: NCT04341012

Sponsor:

Mayo Clinic

Information provided by (Responsible Party):

Tushar Patel, Mayo Clinic

Brief Summary:

The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.

	Condition or disease	Intervention/treatment
1	Liver DiseasesLiver CancerCOVID19	Diagnostic Test: Collection of breath sample

Detailed Description:

The study will seek to collect and analyze breath samples from a broad range of patients to develop reference ranges and to refine the testing methods. Protocols for breath sample collection and algorithms for analysis will be developed. Samples will be collected from normal volunteers, persons with documented liver disease, organ transplant or with known COVID-19 test results.

	Study Type:	Observational
1	EstimatedEnrollment:	120 participants
2	Observational Model:	Cohort
3	Time Perspective:	Prospective
4	Official Title:	Development of a Breath Analysis Test for Disease Diagnosis and Prognosis
5	ActualStudy Start Date:	September 10, 2019
6	EstimatedPrimary Completion Date:	December 31, 2021
7	EstimatedStudy Completion Date:	December 31, 2021

United States, Florida
Mayo Clinic Florida	Recruiting
Jacksonville, Florida, United States, 32224
Contact: Robert Brannock 904-953-2000 [email protected]
Principal Investigator: Tushar Patel, MBChB